Yujiro Aoki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yujiro Aoki has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Ken Sakai
Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
11 shared publications- Masaki Muramatsu
Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
7 shared publications Seiichiro Shishido
Department of Nephrology, Faculty of Medicine, Toho University, Tokyo, Japan
7 shared publicationsTakeshi Kawamura
Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
7 shared publicationsTakashi Yonekura
Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
6 shared publications- Yuko Hamasaki
Department of Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
6 shared publications
Latest Publications
- 2 September 2026
- Published by Springer Nature in CEN Case Reports
- Vol. 15 (5) , 136
Experience with early treatment using febuxostat in a patient with adenine phosphoribosyltransferase deficiency after pediatric kidney transplantation: a case report
- 2 September 2026
- Published by Springer Nature in CEN Case Reports
- Vol. 15 (5) , 136
Experience with early treatment using febuxostat in a patient with adenine phosphoribosyltransferase deficiency after pediatric kidney transplantation: a case report
- 20 February 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (2) , e70388
Survey of Herpes Zoster in Kidney Transplant Patients: A Single‐Center Study
Objectives: Herpes zoster is a frequent complication after kidney transplantation. This study aimed to assess its incidence and associated risk factors in adult kidney transplant recipients. Methods: We retrospectively reviewed cases of herpes zoster that occurred between April 2013 and March 2023 among 714 adult patients who had previously undergone kidney transplantation. Incidence rates were calculated per 1000 person‐years. Patient characteristics were compared between those with and without herpes zoster. Multivariable logistic regression was used to identify independent risk factors. Patients with herpes zoster were categorized into disseminated and localized groups, and their clinical backgrounds were compared. Results: Herpes zoster occurred in 112 patients (15.7%), with an incidence of 22.1 per 1000 person‐years. The median age at onset was 51 years, and the median time from transplantation to onset was 7.8 years. Age‐specific incidence rates per 1000 person‐years were 12.2 (twenties), 24.0 (thirties), 21.7 (forties), 23.9 (fifties), 25.8 (sixties), and 25.3 (≥ seventies). Notably, elevated incidence was evident from the third decade onwards. Independent risk factors included reduced estimated glomerular filtration rate and administration of rabbit anti‐lymphocyte antibodies. Among affected patients, 13 cases were disseminated, 94 were localized, and 5 were unclassified. Disseminated cases showed more frequent anti‐lymphocyte antibody use. Conclusions: Herpes zoster was relatively common, even among younger adult kidney transplant recipients. Strong immunosuppression and impaired renal function may increase the risk of herpes zoster and its dissemination.
- 20 February 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (2) , e70388
Survey of Herpes Zoster in Kidney Transplant Patients: A Single‐Center Study
Objectives: Herpes zoster is a frequent complication after kidney transplantation. This study aimed to assess its incidence and associated risk factors in adult kidney transplant recipients. Methods: We retrospectively reviewed cases of herpes zoster that occurred between April 2013 and March 2023 among 714 adult patients who had previously undergone kidney transplantation. Incidence rates were calculated per 1000 person‐years. Patient characteristics were compared between those with and without herpes zoster. Multivariable logistic regression was used to identify independent risk factors. Patients with herpes zoster were categorized into disseminated and localized groups, and their clinical backgrounds were compared. Results: Herpes zoster occurred in 112 patients (15.7%), with an incidence of 22.1 per 1000 person‐years. The median age at onset was 51 years, and the median time from transplantation to onset was 7.8 years. Age‐specific incidence rates per 1000 person‐years were 12.2 (twenties), 24.0 (thirties), 21.7 (forties), 23.9 (fifties), 25.8 (sixties), and 25.3 (≥ seventies). Notably, elevated incidence was evident from the third decade onwards. Independent risk factors included reduced estimated glomerular filtration rate and administration of rabbit anti‐lymphocyte antibodies. Among affected patients, 13 cases were disseminated, 94 were localized, and 5 were unclassified. Disseminated cases showed more frequent anti‐lymphocyte antibody use. Conclusions: Herpes zoster was relatively common, even among younger adult kidney transplant recipients. Strong immunosuppression and impaired renal function may increase the risk of herpes zoster and its dissemination.
- Open Access
- 1 January 2026
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 39, oa.25-030
Kidney Transplant Outcomes in Pediatric Nephronophthisis in a Single Japanese Center
Background and Purpose: Nephronophthisis (NPH) is a hereditary disease that progresses to end-stage kidney disease at a relatively young age. However, reports on NPH, including outcomes after kidney replacement therapy (KRT), remain limited. We investigated diagnostic triggers, age at detection, extrarenal complications, genetic mutations, KRT, growth, and graft outcome in patients with NPH. Methods: We retrospectively reviewed the medical records of 14 patients with NPH who underwent kidney transplantation (KTx) in our center between 2009 and 2024. This study included 9 (64.3%) males and 5 (35.7%) females. The median age at transplantation was 8.8 years. Results: The most common diagnostic triggers were thoracic hypoplasia, school health checkups, and incidental testing. Extrarenal complications were observed in 9 (64.3%) patients. Among 10 patients who underwent genetic testing, NPH-related gene mutations were identified in 7 (70.0%) patients. Kidney function was well maintained after KTx. The median height standard deviation score (SDS) at transplantation was −2.0. Conclusions: Extrarenal manifestations appear to be useful in the diagnosis of NPH. Although kidney function is well preserved after KTx, improvement of height at transplantation remains an important challenge for catch-up growth.
- 1 January 2026
- Published by Japanese Society for Pediatric Nephrology in Japanese journal of pediatric nephrology
- Vol. 39, oa.25-030
Open AccessKidney Transplant Outcomes in Pediatric Nephronophthisis in a Single Japanese Center
Background and Purpose: Nephronophthisis (NPH) is a hereditary disease that progresses to end-stage kidney disease at a relatively young age. However, reports on NPH, including outcomes after kidney replacement therapy (KRT), remain limited. We investigated diagnostic triggers, age at detection, extrarenal complications, genetic mutations, KRT, growth, and graft outcome in patients with NPH. Methods: We retrospectively reviewed the medical records of 14 patients with NPH who underwent kidney transplantation (KTx) in our center between 2009 and 2024. This study included 9 (64.3%) males and 5 (35.7%) females. The median age at transplantation was 8.8 years. Results: The most common diagnostic triggers were thoracic hypoplasia, school health checkups, and incidental testing. Extrarenal complications were observed in 9 (64.3%) patients. Among 10 patients who underwent genetic testing, NPH-related gene mutations were identified in 7 (70.0%) patients. Kidney function was well maintained after KTx. The median height standard deviation score (SDS) at transplantation was −2.0. Conclusions: Extrarenal manifestations appear to be useful in the diagnosis of NPH. Although kidney function is well preserved after KTx, improvement of height at transplantation remains an important challenge for catch-up growth.
- 8 December 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (5) , 1465-1475
Change in bladder capacity and prognostic predictors of post-transplant vesicoureteral reflux in pediatric kidney transplant recipients: a single-center retrospective cohort study
Background Kidney transplantation (KT) is the preferred treatment for pediatric patients with kidney failure. However, vesicoureteral reflux (VUR) is a common occurrence post-KT. This single-center retrospective cohort study investigated bladder capacity changes and identified post-transplant VUR predictors in pediatric KT recipients. Methods Pediatric patients with or without pre-transplant anuria (< 0.5 mL/kg/h) who underwent KT, from January 2009 to December 2023, were analyzed. Expected bladder capacity (EBC) was calculated based on age. Maximum bladder capacity (MBC) and post-transplant VUR presence were evaluated using voiding cystourethrography. Logistic regression was used to identify independent risk factors for post-transplant VUR. Receiver operating characteristic curve analysis was used to determine the predicted probability of post-transplant VUR. Results Among 93 patients (males: 60%; median age: 6.1 [2.3–17.7] years), 25 (26.9%) had pre-transplant anuria. Bladder capacity (from 37.5 to 120 mL; p < 0.001) and MBC/EBC ratio (from 19.7 to 62.3%; p < 0.001) increased post-KT only in patients with anuria. Multivariate analyses revealed that pre-transplant MBC/EBC ratio predicted post-transplant VUR (odds ratio: 0.982, 95% confidence interval: 0.963–0.999; p = 0.046; sensitivity: 76.5%, specificity: 72.4%, area under the curve: 0.757 [cut-off: 57.8%]). Conclusions Pre-transplant MBC/EBC ratio is a useful bladder capacity indicator and predicts post-transplant VUR in pediatric KT recipients. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 8 December 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (5) , 1465-1475
Change in bladder capacity and prognostic predictors of post-transplant vesicoureteral reflux in pediatric kidney transplant recipients: a single-center retrospective cohort study
Background Kidney transplantation (KT) is the preferred treatment for pediatric patients with kidney failure. However, vesicoureteral reflux (VUR) is a common occurrence post-KT. This single-center retrospective cohort study investigated bladder capacity changes and identified post-transplant VUR predictors in pediatric KT recipients. Methods Pediatric patients with or without pre-transplant anuria (< 0.5 mL/kg/h) who underwent KT, from January 2009 to December 2023, were analyzed. Expected bladder capacity (EBC) was calculated based on age. Maximum bladder capacity (MBC) and post-transplant VUR presence were evaluated using voiding cystourethrography. Logistic regression was used to identify independent risk factors for post-transplant VUR. Receiver operating characteristic curve analysis was used to determine the predicted probability of post-transplant VUR. Results Among 93 patients (males: 60%; median age: 6.1 [2.3–17.7] years), 25 (26.9%) had pre-transplant anuria. Bladder capacity (from 37.5 to 120 mL; p < 0.001) and MBC/EBC ratio (from 19.7 to 62.3%; p < 0.001) increased post-KT only in patients with anuria. Multivariate analyses revealed that pre-transplant MBC/EBC ratio predicted post-transplant VUR (odds ratio: 0.982, 95% confidence interval: 0.963–0.999; p = 0.046; sensitivity: 76.5%, specificity: 72.4%, area under the curve: 0.757 [cut-off: 57.8%]). Conclusions Pre-transplant MBC/EBC ratio is a useful bladder capacity indicator and predicts post-transplant VUR in pediatric KT recipients. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 14 March 2025
- Published by Springer Nature in BMC Urology
- Vol. 25 (1) , 1-7
Acute kidney injury caused by ureteral obstruction after Deflux® injection treatment for vesicoureteral reflux after pediatric kidney transplantation: a case report
Background: Vesicoureteral reflux (VUR) after pediatric kidney transplantation (KT) is a frequent urologic complication. Endoscopic Deflux® injection is a treatment option. However, ureteral obstruction after Deflux® injection treatment is a potential complication that may have serious outcomes for patients who have undergone KT. We report a case of acute kidney injury (AKI) caused by ureteral obstruction with acute foreign body reaction immediately after Deflux® injection treatment for VUR after transplantation. Case presentation: We encountered a 5-year-old boy who underwent living-donor KT at age 4 years because of end-stage kidney disease caused by posterior urethral valves. At 4 months after KT, VUR (grade IV) and bladder dysfunction worsening were detected by voiding cystourethrography. A second febrile urinary tract infection (UTI) was treated with endoscopic Deflux® injection in the neo-orifice of the transplanted kidney after 2 weeks of antimicrobial therapy. Postoperatively, the patient experienced a temporary decrease in urine output. Increased creatinine was observed on postoperative day 1. The renal pelvis was more dilated than it was preoperatively, and ureteral dilatation was observed. A bulge associated with Deflux® injection, consistent with the injection site, was observed in the bladder. Additionally, because the graft function continued to decline, AKI associated with ureteral obstruction after Deflux® injection treatment was diagnosed, and a ureteral stent was placed on postoperative day 4. The graft function gradually recovered. Four months later, the ureteral stent was removed. Exacerbation of hydronephrosis of the transplanted kidney was not observed, and the graft function was stable. Although the patient experienced residual VUR after KT, excretion control was continued and UTI recurrence was not observed. Conclusions: Ureteral obstruction after Deflux® injection treatment for VUR after transplantation is a serious complication; therefore, treatment indications and timing should be carefully considered.
- 14 March 2025
- Published by Springer Nature in BMC Urology
- Vol. 25 (1) , 1-7
Open AccessAcute kidney injury caused by ureteral obstruction after Deflux® injection treatment for vesicoureteral reflux after pediatric kidney transplantation: a case report
Background: Vesicoureteral reflux (VUR) after pediatric kidney transplantation (KT) is a frequent urologic complication. Endoscopic Deflux® injection is a treatment option. However, ureteral obstruction after Deflux® injection treatment is a potential complication that may have serious outcomes for patients who have undergone KT. We report a case of acute kidney injury (AKI) caused by ureteral obstruction with acute foreign body reaction immediately after Deflux® injection treatment for VUR after transplantation. Case presentation: We encountered a 5-year-old boy who underwent living-donor KT at age 4 years because of end-stage kidney disease caused by posterior urethral valves. At 4 months after KT, VUR (grade IV) and bladder dysfunction worsening were detected by voiding cystourethrography. A second febrile urinary tract infection (UTI) was treated with endoscopic Deflux® injection in the neo-orifice of the transplanted kidney after 2 weeks of antimicrobial therapy. Postoperatively, the patient experienced a temporary decrease in urine output. Increased creatinine was observed on postoperative day 1. The renal pelvis was more dilated than it was preoperatively, and ureteral dilatation was observed. A bulge associated with Deflux® injection, consistent with the injection site, was observed in the bladder. Additionally, because the graft function continued to decline, AKI associated with ureteral obstruction after Deflux® injection treatment was diagnosed, and a ureteral stent was placed on postoperative day 4. The graft function gradually recovered. Four months later, the ureteral stent was removed. Exacerbation of hydronephrosis of the transplanted kidney was not observed, and the graft function was stable. Although the patient experienced residual VUR after KT, excretion control was continued and UTI recurrence was not observed. Conclusions: Ureteral obstruction after Deflux® injection treatment for VUR after transplantation is a serious complication; therefore, treatment indications and timing should be carefully considered.
- Open Access
- 21 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (25) , e38649
Comparison of preemptive and non-preemptive kidney transplantation outcomes in children aged <6 years
We aimed to compare the outcomes of pediatric kidney transplantation (KT) between preemptive KT (PEKT) and non-PEKT in children aged < 6 years. Seventy-four pediatric recipients aged < 6 years who underwent KT were divided into the PEKT and non-PEKT groups. They were retrospectively evaluated for patient and graft survival, graft function, growth, and cytomegalovirus (CMV) infection. Comparison of the groups (PEKT, n = 14; non-PEKT, n = 60) revealed no significant differences between them in terms of distribution of sex, age, weight, primary disease, or population of pre-transplant CMV immunoglobulin G-positive patients. The median estimated glomerular filtration rate before KT in the PEKT and non-PEKT groups was 11.4 and 7.3 (mL/min/1.73 m2) (P < .001), respectively, and the median duration of dialysis was 2.7 years in the non-PEKT group. Graft survival at 5 years was 100% and 95% in the PEKT and non-PEKT groups, respectively (P = .634). One patient in the non-PEKT group had vascular complications, with subsequent early graft loss. Incidence of CMV infection was significantly lower in the PEKT group (P = .044). There were no significant differences in post-transplant estimated glomerular filtration rate, acute rejection, or growth. The height standard deviation score showed catch-up growth after KT in both groups. There was no significant difference in transplant outcomes in recipients aged < 6 years, with or without pre-transplant dialysis, except for the incidence of CMV infection. Therefore, PEKT in younger children should be performed aggressively by experienced multi-disciplinary teams.
- 21 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (25) , e38649
Open AccessComparison of preemptive and non-preemptive kidney transplantation outcomes in children aged <6 years
We aimed to compare the outcomes of pediatric kidney transplantation (KT) between preemptive KT (PEKT) and non-PEKT in children aged < 6 years. Seventy-four pediatric recipients aged < 6 years who underwent KT were divided into the PEKT and non-PEKT groups. They were retrospectively evaluated for patient and graft survival, graft function, growth, and cytomegalovirus (CMV) infection. Comparison of the groups (PEKT, n = 14; non-PEKT, n = 60) revealed no significant differences between them in terms of distribution of sex, age, weight, primary disease, or population of pre-transplant CMV immunoglobulin G-positive patients. The median estimated glomerular filtration rate before KT in the PEKT and non-PEKT groups was 11.4 and 7.3 (mL/min/1.73 m2) (P < .001), respectively, and the median duration of dialysis was 2.7 years in the non-PEKT group. Graft survival at 5 years was 100% and 95% in the PEKT and non-PEKT groups, respectively (P = .634). One patient in the non-PEKT group had vascular complications, with subsequent early graft loss. Incidence of CMV infection was significantly lower in the PEKT group (P = .044). There were no significant differences in post-transplant estimated glomerular filtration rate, acute rejection, or growth. The height standard deviation score showed catch-up growth after KT in both groups. There was no significant difference in transplant outcomes in recipients aged < 6 years, with or without pre-transplant dialysis, except for the incidence of CMV infection. Therefore, PEKT in younger children should be performed aggressively by experienced multi-disciplinary teams.
- Open Access
- 5 June 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-7
Arteriovenous fistula in a renal allograft with gross hematuria and subsequent acute kidney injury due to urinary tract obstruction: a case report
Background: Arteriovenous fistula (AVF) due to renal allograft biopsy is mechanical trauma resulting from the penetration of small arteries and veins by a core needle. Most AVFs are reported to resolve asymptomatically and spontaneously. This report presents a patient with acute kidney injury (AKI) due to urinary tract obstruction caused by a bleeding AVF in a renal allograft. Case presentation: A 22-year-old Japanese woman who underwent living-donor kidney transplantation (KT) at 3 years due to end-stage renal disease caused by focal segmental glomerulosclerosis (FSGS) presented with a renal transplant AVF (gourd-shaped; 42 × 19 × 20 mm). The AVF was unexpectedly discovered by ultrasound before a surveillance biopsy at 10 years after KT. The patient had a history of recurrent FSGS, had undergone several renal allograft biopsies after KT, and did not experience symptoms or growth of the AVF for years. Nineteen years after KT, the patient developed AKI with sudden, asymptomatic, gross hematuria and anuria. Plain computed tomography revealed a hematoma in the pelvis of the renal allograft and bladder tamponade. The AVF was successfully treated by coil embolization. Hemodialysis was performed for AKI, and graft function was gradually recovered. Conclusions: Unexpected bleeding from a renal transplant AVF may lead to transplant dysfunction. Angiographic embolization against the ruptured renal transplant AVF may prevent rebleeding and rescue the renal allograft.
- 5 June 2023
- Published by Springer Nature in BMC Nephrology
- Vol. 24 (1) , 1-7
Open AccessArteriovenous fistula in a renal allograft with gross hematuria and subsequent acute kidney injury due to urinary tract obstruction: a case report
Background: Arteriovenous fistula (AVF) due to renal allograft biopsy is mechanical trauma resulting from the penetration of small arteries and veins by a core needle. Most AVFs are reported to resolve asymptomatically and spontaneously. This report presents a patient with acute kidney injury (AKI) due to urinary tract obstruction caused by a bleeding AVF in a renal allograft. Case presentation: A 22-year-old Japanese woman who underwent living-donor kidney transplantation (KT) at 3 years due to end-stage renal disease caused by focal segmental glomerulosclerosis (FSGS) presented with a renal transplant AVF (gourd-shaped; 42 × 19 × 20 mm). The AVF was unexpectedly discovered by ultrasound before a surveillance biopsy at 10 years after KT. The patient had a history of recurrent FSGS, had undergone several renal allograft biopsies after KT, and did not experience symptoms or growth of the AVF for years. Nineteen years after KT, the patient developed AKI with sudden, asymptomatic, gross hematuria and anuria. Plain computed tomography revealed a hematoma in the pelvis of the renal allograft and bladder tamponade. The AVF was successfully treated by coil embolization. Hemodialysis was performed for AKI, and graft function was gradually recovered. Conclusions: Unexpected bleeding from a renal transplant AVF may lead to transplant dysfunction. Angiographic embolization against the ruptured renal transplant AVF may prevent rebleeding and rescue the renal allograft.
- 5 December 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (2) , e14440
Fibroblast growth factor 23‐Klotho and mineral metabolism in the first year after pediatric kidney transplantation: A single‐center prospective study
Background: The role of fibroblast growth factor 23 (FGF23) levels in mineral metabolism before and after kidney transplantation in pediatric patients is poorly understood.Methods: We prospectively evaluated 24 patients under 18 years of age (4.5 [3.3–9.8] years) who underwent living kidney transplantation between July 2016 and March 2018, and measured intact FGF23 and serum αKlotho levels, and other parameters of mineral metabolism before and after transplantation (Day 7, 1 and 4 months, and 1 year). Relationships between parameters were examined by linear analysis.Results: FGF23 level was 440.8 [63.4–5916.3] pg/ml pre‐transplant and decreased significantly to 37.1 [16.0–71.5] pg/ml at Day 7 post‐transplant (−91.6%, p < .001). Thereafter, it remained at normal levels until 1 year. αKlotho level was 785 [568–1292] pg/ml pre‐transplant and remained low at Day 7 and 1 month post‐transplant, with an increasing trend at 4 months. Post‐transplant phosphorus levels were significantly decreased compared with pre‐transplant, with a lowest level of 1.7 [1.3–2.9] mg/dl, −5.7 [−6.8, −3.8] SD at Day 4, followed by gradual recovery. Phosphorus levels and the ratio of tubular maximum phosphate reabsorption were significantly and negatively associated with pre‐transplant FGF23 until 4 months of post‐transplant. Pre‐transplant αKlotho was negatively associated with pre‐transplant FGF23 but not FGF23 or other parameters after transplantation.Conclusion: FGF23 in pediatric kidney transplant patients decreased rapidly after transplantation and associated with post‐transplant hypophosphatemia and increased phosphorus excretion. Post‐transplant αKlotho was low early post‐transplant but tended to increase subsequently. Post‐transplant αKlotho was unaffected by pre‐transplant FGF23 or other factors, suggesting pre‐transplant chronic kidney disease status has no effect.
- 5 December 2022
- Published by Wiley in Pediatric Transplantation
- Vol. 27 (2) , e14440
Fibroblast growth factor 23‐Klotho and mineral metabolism in the first year after pediatric kidney transplantation: A single‐center prospective study
Background: The role of fibroblast growth factor 23 (FGF23) levels in mineral metabolism before and after kidney transplantation in pediatric patients is poorly understood.Methods: We prospectively evaluated 24 patients under 18 years of age (4.5 [3.3–9.8] years) who underwent living kidney transplantation between July 2016 and March 2018, and measured intact FGF23 and serum αKlotho levels, and other parameters of mineral metabolism before and after transplantation (Day 7, 1 and 4 months, and 1 year). Relationships between parameters were examined by linear analysis.Results: FGF23 level was 440.8 [63.4–5916.3] pg/ml pre‐transplant and decreased significantly to 37.1 [16.0–71.5] pg/ml at Day 7 post‐transplant (−91.6%, p < .001). Thereafter, it remained at normal levels until 1 year. αKlotho level was 785 [568–1292] pg/ml pre‐transplant and remained low at Day 7 and 1 month post‐transplant, with an increasing trend at 4 months. Post‐transplant phosphorus levels were significantly decreased compared with pre‐transplant, with a lowest level of 1.7 [1.3–2.9] mg/dl, −5.7 [−6.8, −3.8] SD at Day 4, followed by gradual recovery. Phosphorus levels and the ratio of tubular maximum phosphate reabsorption were significantly and negatively associated with pre‐transplant FGF23 until 4 months of post‐transplant. Pre‐transplant αKlotho was negatively associated with pre‐transplant FGF23 but not FGF23 or other parameters after transplantation.Conclusion: FGF23 in pediatric kidney transplant patients decreased rapidly after transplantation and associated with post‐transplant hypophosphatemia and increased phosphorus excretion. Post‐transplant αKlotho was low early post‐transplant but tended to increase subsequently. Post‐transplant αKlotho was unaffected by pre‐transplant FGF23 or other factors, suggesting pre‐transplant chronic kidney disease status has no effect.
- 6 June 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (9) , 1017-1025
Outcome of ABO‐incompatible kidney transplantation using a modified desensitization protocol without plasmapheresis
Objectives: Several controversies regarding desensitization strategies for successful ABO‐incompatible (ABOi) kidney transplantation still exist. This study aimed to investigate whether pretransplant anti‐A/B antibody removal is mandatory in an ABOi kidney transplant recipient with low baseline isoagglutinin titers.Methods: We adopted a modified desensitization protocol with two doses of rituximab (RTX, 100 mg/body) without pretransplant antibody removal for ABOi kidney transplant recipients with a titer of ≤1:64 (group A; n = 35) and investigated the feasibility of this protocol by comparing it with the clinical outcomes of patients undergoing standard pretransplant plasmapheresis (group B; n = 21).Results: There was no significant difference in the rate of antibody‐mediated rejection within the first month after transplantation between the two groups (11.4% in group A vs. 2% in group B, p = 0.6019). Moreover, no differences were observed in the short‐ and long‐term graft outcomes between the groups. However, two major critical acute antibody‐mediated events occurred in group A; one patient lost the graft due to hyperacute rejection, and the other patient developed thrombotic microangiopathy after surgery. Risk factors predicting these perioperative complications were not identified.Conclusions: We conclude that not only B‐cell depletion using RTX but also pretransplant antibody removal is still recommended even for patients with low isoagglutinin titers. In addition, a new diagnostic tool is needed for accurate risk stratification.
- 6 June 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (9) , 1017-1025
Outcome of ABO‐incompatible kidney transplantation using a modified desensitization protocol without plasmapheresis
Objectives: Several controversies regarding desensitization strategies for successful ABO‐incompatible (ABOi) kidney transplantation still exist. This study aimed to investigate whether pretransplant anti‐A/B antibody removal is mandatory in an ABOi kidney transplant recipient with low baseline isoagglutinin titers.Methods: We adopted a modified desensitization protocol with two doses of rituximab (RTX, 100 mg/body) without pretransplant antibody removal for ABOi kidney transplant recipients with a titer of ≤1:64 (group A; n = 35) and investigated the feasibility of this protocol by comparing it with the clinical outcomes of patients undergoing standard pretransplant plasmapheresis (group B; n = 21).Results: There was no significant difference in the rate of antibody‐mediated rejection within the first month after transplantation between the two groups (11.4% in group A vs. 2% in group B, p = 0.6019). Moreover, no differences were observed in the short‐ and long‐term graft outcomes between the groups. However, two major critical acute antibody‐mediated events occurred in group A; one patient lost the graft due to hyperacute rejection, and the other patient developed thrombotic microangiopathy after surgery. Risk factors predicting these perioperative complications were not identified.Conclusions: We conclude that not only B‐cell depletion using RTX but also pretransplant antibody removal is still recommended even for patients with low isoagglutinin titers. In addition, a new diagnostic tool is needed for accurate risk stratification.
- Open Access
- 20 October 2021
- Published by Japanese Urological Association in The Japanese Journal of Urology
- Vol. 112 (4) , 168-172
TETHERED CORD SYNDROME IN CHILDREN WITH DAYTIME INCONTINENCE
(背景) 脊髄係留症候群とは脊髄下端が尾側組織に係留し,さまざまな神経障害をきたすことをいう.中でも排尿障害は早期に出現することが多い.昼間尿失禁を主訴に泌尿器科を受診し,脊髄係留症候群の診断に至った小児症例について検討した. (対象と方法) 2011年3月から2017年10月に昼間尿失禁を主訴に泌尿器科を受診し,脊髄係留症候群と診断された18例.脊髄係留症候群の診断契機,係留解除術前後の臨床症状の変化について検討した. (結果) 男児9例,女児9例.初診時の平均年齢は6.3歳(範囲4~9歳).難治性の昼間尿失禁として全例にウロダイナミクスおよびVCUGを施行した.全例に脊仙MRIを施行し,その理由はVCUGおよびウロナミクスでの異常所見の精査であった.終糸脂肪腫8例,潜在性脊髄係留症候群4例,低位脊髄円錐4例,円錐部脂肪腫1例,仙骨内髄膜囊胞1例でMRIでの解剖学的脊髄係留所見を認めたのは4例のみであった.脊髄係留解除術後の平均観察期間は66.3カ月(22~116カ月)で,11例で無症状,4例は夜尿症のみが残存,3例は間欠導尿での管理となっている. (結語) 昼間尿失禁が脊髄係留症候群の症状の一つとなっている症例が存在することを想定し,診療を行う必要がある.ウロダイナミクスでの膀胱機能評価が,脊髄係留症候群の診断契機となりうる.
- 20 October 2021
- Published by Japanese Urological Association in The Japanese Journal of Urology
- Vol. 112 (4) , 168-172
Open AccessTETHERED CORD SYNDROME IN CHILDREN WITH DAYTIME INCONTINENCE
(背景) 脊髄係留症候群とは脊髄下端が尾側組織に係留し,さまざまな神経障害をきたすことをいう.中でも排尿障害は早期に出現することが多い.昼間尿失禁を主訴に泌尿器科を受診し,脊髄係留症候群の診断に至った小児症例について検討した. (対象と方法) 2011年3月から2017年10月に昼間尿失禁を主訴に泌尿器科を受診し,脊髄係留症候群と診断された18例.脊髄係留症候群の診断契機,係留解除術前後の臨床症状の変化について検討した. (結果) 男児9例,女児9例.初診時の平均年齢は6.3歳(範囲4~9歳).難治性の昼間尿失禁として全例にウロダイナミクスおよびVCUGを施行した.全例に脊仙MRIを施行し,その理由はVCUGおよびウロナミクスでの異常所見の精査であった.終糸脂肪腫8例,潜在性脊髄係留症候群4例,低位脊髄円錐4例,円錐部脂肪腫1例,仙骨内髄膜囊胞1例でMRIでの解剖学的脊髄係留所見を認めたのは4例のみであった.脊髄係留解除術後の平均観察期間は66.3カ月(22~116カ月)で,11例で無症状,4例は夜尿症のみが残存,3例は間欠導尿での管理となっている. (結語) 昼間尿失禁が脊髄係留症候群の症状の一つとなっている症例が存在することを想定し,診療を行う必要がある.ウロダイナミクスでの膀胱機能評価が,脊髄係留症候群の診断契機となりうる.